{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:33:25Z","timestamp":1754159605190,"version":"3.41.2"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.annpat.2025.04.002","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T07:15:57Z","timestamp":1746515757000},"page":"334-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Les l\u00e9sions T folliculaires helper et \u00ab\u00a0mimickers\u00a0\u00bb en dermatopathologie\u00a0: de la th\u00e9orie \u00e0 la pratique"],"prefix":"10.1016","volume":"45","author":[{"given":"Fanny","family":"Beltzung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Laure","family":"Julli\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Parrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Vergier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2025.04.002_bib0350","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1051\/medsci\/20173310020","article-title":"Lymphocytes T folliculaires helper et VIH\u00a0: unis pour le meilleur et pour le pire","volume":"33","author":"Rouers","year":"2017","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/j.annpat.2025.04.002_bib0355","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/exd.13842","article-title":"Increased expression of PD 1\u00a0and CD 39\u00a0on CD 3+ CD 4+ skin T cells in the elderly","volume":"28","author":"Zuelgaray","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0360","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd2712","article-title":"Revisiting the PD-1\u00a0pathway","volume":"6","author":"Patsoukis","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.annpat.2025.04.002_bib0365","doi-asserted-by":"crossref","first-page":"E488","DOI":"10.1073\/pnas.1100898108","article-title":"Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers","volume":"108","author":"Bentebibel","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.annpat.2025.04.002_bib0370","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1084\/jem.20141380","article-title":"BCL6\u00a0orchestrates Tfh cell differentiation via multiple distinct mechanisms","volume":"212","author":"Hatzi","year":"2015","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.annpat.2025.04.002_bib0375","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0380","doi-asserted-by":"crossref","first-page":"385","DOI":"10.21037\/atm.2017.06.11","article-title":"Molecular mechanisms of programmed cell death-1\u00a0dependent T cell suppression: relevance for immunotherapy","volume":"5","author":"Zuazo","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.annpat.2025.04.002_bib0385","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.intimp.2017.03.015","article-title":"Primary and acquired resistance to PD-1\/PD-L1\u00a0blockade in cancer treatment","volume":"46","author":"Wang","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0390","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/14712598.2020.1693540","article-title":"Role of inducible co-stimulator (ICOS) in cancer immunotherapy","volume":"20","author":"Amatore","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.annpat.2025.04.002_bib0395","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.4049\/jimmunol.179.8.5099","article-title":"Role of CXCR5\u00a0and CCR7\u00a0in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation","volume":"179","author":"Haynes","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0400","doi-asserted-by":"crossref","first-page":"102976","DOI":"10.1016\/j.jaut.2022.102976","article-title":"T follicular helper cells in autoimmune diseases","volume":"134","author":"Wei","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.annpat.2025.04.002_bib0405","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood.V84.3.830.bloodjournal843830","article-title":"Expression of the G-protein\u00a0\u2013\u00a0coupled receptor BLR1\u00a0defines mature, recirculating B cells and a subset of T-helper memory cells","volume":"84","author":"F\u00f6rster","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2025.04.002_bib0410","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41577-022-00693-5","article-title":"The link between circulating follicular helper T cells and autoimmunity","volume":"22","author":"Walker","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0415","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.4049\/jimmunol.179.8.5099","article-title":"Role of CXCR5\u00a0and CCR7\u00a0in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation","volume":"179","author":"Haynes","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0420","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.it.2014.06.002","article-title":"Phenotype and functions of memory Tfh cells in human blood","volume":"35","author":"Schmitt","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0425","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/art.23966","article-title":"Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13\u00a0in the inflammatory environment of the rheumatoid joint","volume":"58","author":"Manzo","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annpat.2025.04.002_bib0430","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.annpat.2025.04.002_bib0435","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/intimm\/dxad041","article-title":"Peripheral helper T cells, mavericks of peripheral immune responses","volume":"36","author":"Yoshitomi","year":"2024","journal-title":"Int Immunol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0440","doi-asserted-by":"crossref","first-page":"1145573","DOI":"10.3389\/fimmu.2023.1145573","article-title":"T peripheral helper cells in autoimmune diseases: what do we know?","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0445","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10238-021-00713-z","article-title":"Altered peripheral helper T cells in peripheral blood and muscle tissue of the patients with dermatomyositis","volume":"21","author":"Hou","year":"2021","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.annpat.2025.04.002_bib0450","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.annpat.2025.04.002_bib0455","doi-asserted-by":"crossref","first-page":"1145573","DOI":"10.3389\/fimmu.2023.1145573","article-title":"T peripheral helper cells in autoimmune diseases: what do we know?","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0460","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/pcmr.12763","article-title":"Imbalance of peripheral follicular helper T lymphocyte subsets in active vitiligo","volume":"32","author":"Jacquemin","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.annpat.2025.04.002_bib0465","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10238-023-01286-9","article-title":"The relationship between peripheral T follicular helper cells and disease severity in systemic sclerosis","volume":"24","author":"Sahinoglu","year":"2024","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.annpat.2025.04.002_bib0470","first-page":"4434","article-title":"Pathogenic role of circulating CD4+CXCR5+ cell subpopulations in patients with chronic spontaneous urticarial","volume":"12","author":"Gao","year":"2020","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.annpat.2025.04.002_bib0475","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.imlet.2020.11.005","article-title":"Increased peripheral helper T cells type 17\u00a0subset correlates with the severity of psoriasis vulgaris","volume":"229","author":"Liu","year":"2021","journal-title":"Immunol Lett"},{"key":"10.1016\/j.annpat.2025.04.002_bib0480","doi-asserted-by":"crossref","first-page":"e27687","DOI":"10.1016\/j.heliyon.2024.e27687","article-title":"Circulating TIGIT\u00b1 PD1+ TPH, TIGIT\u00b1 PD1+ TFH cells are elevated and their predicting role in systemic lupus erythematosus","volume":"10","author":"Luo","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.annpat.2025.04.002_bib0485","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.imlet.2017.04.010","article-title":"Expansion of circulating follicular T helper cells associates with disease severity in childhood atopic dermatitis","volume":"189","author":"Szab\u00f3","year":"2017","journal-title":"Immunol Lett"},{"key":"10.1016\/j.annpat.2025.04.002_bib0490","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/jdv.16780","article-title":"Expression of PD-1\u00a0and Tim-3\u00a0is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris","volume":"35","author":"Ernst","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0495","first-page":"850","article-title":"Neoplastic cells of primary cutaneous CD4+ small\/medium-sized pleomorphic t-cell lymphoma lack the expression of follicular T-helper cell defining chemokine receptor CXCR5","volume":"96","author":"Kren\u00e1cs","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/25785826.2020.1776079","article-title":"T follicular helper cell subsets: a potential key player in autoimmunity","volume":"44","author":"Kurata","year":"2021","journal-title":"Immunol Med"},{"key":"10.1016\/j.annpat.2025.04.002_bib0505","doi-asserted-by":"crossref","first-page":"1264508","DOI":"10.3389\/fimmu.2023.1264508","article-title":"Dysregulation of circulating T follicular helper cell subsets and their potential role in the pathogenesis of syphilis","volume":"14","author":"Shen","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0510","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bjd.13832","article-title":"Histopathological and immunophenotypical criteria for the diagnosis of S\u00e9zary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 9","volume":"173","author":"Klemke","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0515","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1182\/bloodadvances.2020002395","article-title":"ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells","volume":"4","author":"Amatore","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.annpat.2025.04.002_bib0520","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1158\/0008-5472.CAN-08-0602","article-title":"CXCL13\u00a0is highly produced by S\u00e9zary cells and enhances their migratory ability via a synergistic mechanism involving CCL19\u00a0and CCL21\u00a0chemokines","volume":"68","author":"Picchio","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.annpat.2025.04.002_bib0525","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/modpathol.2012.124","article-title":"Follicular center helper T-cell (TFH) marker positive mycosis fungoides\/Sezary syndrome","volume":"26","author":"Meyerson","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0530","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.1062","article-title":"A high programmed cell death protein 1\u00a0hormone receptor score on skin biopsy is associated with S\u00e9zary syndrome diagnosis: a study of 91\u00a0patients with erythroderma","volume":"102","author":"Luherne","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0535","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/bjd.21063","article-title":"Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1\u00a0and inducible T-cell co-stimulator in mycosis fungoides and S\u00e9zary syndrome: association with disease stage and clinical outcome","volume":"187","author":"Di Raimondo","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0540","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0959-8049(21)00652-3","article-title":"PD1\u00a0in S\u00e9zary syndrome: a repressor of cell survival sometimes lost during progression, but a new target using depleting antibodies?","volume":"156","author":"Decroos","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annpat.2025.04.002_bib0545","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.19.01056","article-title":"Pembrolizumab in relapsed and refractory mycosis fungoides and S\u00e9zary syndrome: a multicenter phase II study","volume":"38","author":"Khodadoust","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0550","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/bloodadvances.2020002371","article-title":"Pembrolizumab in mycosis fungoides with PD-L1\u00a0structural variants","volume":"5","author":"Beygi","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.annpat.2025.04.002_bib0555","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1038\/s41467-021-26974-6","article-title":"Immune cell topography predicts response to PD-1\u00a0blockade in cutaneous T cell lymphoma","volume":"12","author":"Phillips","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.annpat.2025.04.002_bib0560","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/dermatopathology10040038","article-title":"Folliculotropic mycosis fungoides is associated with decreased PD1\u00a0staining compared with classic mycosis fungoides","volume":"10","author":"Tang","year":"2023","journal-title":"Dermatopathology"},{"key":"10.1016\/j.annpat.2025.04.002_bib0565","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/cells13050419","article-title":"Differential upregulation of Th1\/Th17-associated proteins and PD-L1\u00a0in granulomatous mycosis fungoides","volume":"13","author":"Marques-Piubelli","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.annpat.2025.04.002_bib0570","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/PAS.0000000000001470","article-title":"Primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorders: a clinical, pathologic, and molecular study of 60\u00a0cases presenting with a single lesion: a multicenter study of the French Cutaneous Lymphoma Study Group","volume":"44","author":"Beltzung","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0575","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136\u00a0cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0580","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1159\/000511473","article-title":"The clinical spectrum of primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoproliferative disorder: an updated systematic literature review and case series","volume":"237","author":"Surmanowicz","year":"2021","journal-title":"Dermatology"},{"issue":"12","key":"10.1016\/j.annpat.2025.04.002_bib0585","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1097\/DAD.0000000000001979","article-title":"Prominent blasts in primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorder. A reconsideration of diagnostic criteria","volume":"43","author":"Bakr","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0590","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/cup.14609","article-title":"Cutaneous lymphoproliferative disorders: back to the future","volume":"51","author":"Willemze","year":"2024","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.annpat.2025.04.002_bib0595","first-page":"850","article-title":"Neoplastic cells of primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma lack expression of follicular T-helper cell defining chemokine receptor CXCR5","volume":"96","author":"Kren\u00e1cs","year":"2016","journal-title":"Acta Derm Venerol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0600","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/path.6222","article-title":"CD27\/CD70\u00a0pathway activation in primary cutaneous CD4+small\/medium T-cell lymphoproliferative disorder","volume":"262","author":"Richter","year":"2024","journal-title":"J Pathol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0605","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/bjd\/ljae192","article-title":"Mutational profiling of primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorder does not resemble nodal peripheral T-cell lymphomas with a follicular helper T-cell phenotype","volume":"191","author":"Rodr\u00edguez","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0610","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/bloodadvances.2021005714","article-title":"Targeting CD70\u00a0in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft models","volume":"6","author":"Wu","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.annpat.2025.04.002_bib0615","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.annpat.2025.04.002_bib0620","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2025.04.002_bib0625","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2\u00a0mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2025.04.002_bib0630","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.annpat.2025.04.002_bib0635","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/PAS.0000000000000956","article-title":"Expression of TFH markers and detection of RHOA p.G17V and IDH2\u00a0p.R172K\/S mutations in cutaneous localizations of angioimmunoblastic T-Cell lymphomas","volume":"41","author":"Leclaire Alirkilicarslan","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0640","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/bjd.21791","article-title":"Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study","volume":"187","author":"Wang","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0645","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1038\/s41598-023-33031-3","article-title":"Deciphering the spectrum of cutaneous lymphomas expressing TFH markers","volume":"13","author":"Donzel","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.annpat.2025.04.002_bib0650","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/DAD.0000000000000144","article-title":"Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics","volume":"37","author":"Botros","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0655","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.12788\/cutis.0498","article-title":"Angioimmunoblastic T-cell lymphoma mimicking DRESS syndrome","volume":"109","author":"Keefe","year":"2022","journal-title":"Cutis"},{"key":"10.1016\/j.annpat.2025.04.002_bib0660","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00428-022-03421-5","article-title":"Recent advances in cutaneous lymphoma\u00a0\u2014\u00a0implications for current and future classifications","volume":"482","author":"Goodlad","year":"2023","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1016\/j.annpat.2025.04.002_bib0665","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/his.15377","article-title":"Recurrent primary cutaneous marginal zone lymphoma: a comparative study of initial tumours, recurrences, and outcomes in 61 patients","volume":"86","author":"Beltzung","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2025.04.002_bib0670","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1097\/DAD.0000000000002003","article-title":"Primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorder or primary cutaneous marginal zone B-cell lymphoma? Two distinct entities with overlapping histopathological features","volume":"43","author":"Bakr","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0675","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/PAS.0000000000001984","article-title":"Overlapping features of primary cutaneous marginal zone lymphoproliferative disorder and primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorder: a diagnostic challenge examined by genomic analysis","volume":"47","author":"Obiorah","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.annpat.2025.04.002_bib0680","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1097\/DAD.0000000000002017","article-title":"Follicular T-helper cells in marginal zone lymphoma: evidence of an organoid immune response","volume":"43","author":"Robson","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0685","doi-asserted-by":"crossref","first-page":"152101","DOI":"10.1016\/j.anndiagpath.2022.152101","article-title":"Primary cutaneous blastic marginal zone lymphoma: a comprehensive clinical, light microscopic, phenotypic and cytogenetic appraisal","volume":"63","author":"Magro","year":"2023","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.annpat.2025.04.002_bib0690","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.2021012057","article-title":"Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC","volume":"140","author":"Olsen","year":"2022","journal-title":"Blood"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024264982500063X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024264982500063X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T16:42:59Z","timestamp":1753461779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S024264982500063X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S024264982500063X"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2025.04.002","relation":{},"ISSN":["0242-6498"],"issn-type":[{"type":"print","value":"0242-6498"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les l\u00e9sions T folliculaires helper et \u00ab\u00a0mimickers\u00a0\u00bb en dermatopathologie\u00a0: de la th\u00e9orie \u00e0 la pratique","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2025.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}